DMAA
Newsroom

FOR IMMEDIATE RELEASE
August 15, 2006

Contact: Carl Graziano
Director, Strategic Communications
(202) 737-5781
cgraziano@dmaa.org

DMAA Advances Outcomes Project with AHRQ-Joint Commission Roundtable

WASHINGTON, DC—The Disease Management Association of America (DMAA) next month will convene purchasers and other key stakeholders—including the federal Agency for Healthcare Research and Quality (AHRQ)—for a roundtable discussion on consensus guidelines for measuring disease management outcomes.

The Sept. 11 roundtable, co-hosted by DMAA, AHRQ and the Joint Commission on Accreditation of Healthcare Organizations, will mark a significant step toward final outcomes measurement guidelines, which DMAA plans to unveil at its Dec. 3 to 5 Disease Management Leadership Forum, in Denver.

The roundtable, at AHRQ headquarters, in Rockville, Md., will focus on building consensus around areas of divergence in measurement methodologies identified through a comprehensive survey of disease management organizations, which DMAA conducted earlier this year as part of the outcomes project it launched in January. The roundtable will include key purchaser and payer stakeholders, including employers, health plans, benefits consultants and other recognized experts in evaluating disease management programs.

Points of discussion at the roundtable will include how to increase confidence in evaluation methodologies; barriers to greater standardization in outcomes measurement; the contribution research and accreditation can make to the credibility of measures; and approaches to promoting standardized program evaluation.

"We've learned much about the varied approaches to evaluating clinical and financial outcomes, and found an encouraging degree of consensus through our survey," DMAA Executive Director Tracey Moorhead said. "Now, as we move toward the final stages of our project, we have turned to the real challenge: reconciling differences to craft guidelines all stakeholders can support."

DMAA enlisted the University of Chicago's National Opinion Research Center (NORC) to analyze and present for review a rich body of data from the outcomes survey. An internal process, including an intensive review of the NORC analysis by multiple work groups of the DMAA Outcomes Steering Committee, leads up to the roundtable and final consideration by the DMAA Board of Directors.

DMAA has reached out to a broad coalition of public and private quality and standards-setting entities to enlist their assistance and support as the project moves forward. Relationships already established include those with URAC, the National Committee for Quality Assurance, the Case Management Society of America, the Society of Actuaries and third-party evaluators and researchers.

"We understand the critical importance of bringing all stakeholders to the table for this process," Moorhead says. "Consensus is key, and we expect to achieve consensus and meet our goal of producing sound guidelines by year's end."

# # #

Reporters, please note: The roundtable will not be open to the media or public.

About DMAA
The DMAA is a nonprofit, voluntary membership association representing all stakeholders in disease management and care coordination. Through advocacy targeting the health care industry, government agencies, employers and the general public, the DMAA promotes the important role disease management and care coordination play in improving care quality and outcomes for people with chronic conditions. Visit the DMAA online at www.dmaa.org.



Chronic Care Professional Certification—DMAA Member Discounts Now Available.

Chronic Care Professional CertificationLearn how Chronic Care Professional certification, available at a discount to DMAA members through a special partnership with the HealthSciences Institute, brings valuable benefits to you and your organization. Go >>

DMAA Membership

Advocacy, research, education and more—the value of DMAA membership is clear. Learn more about who we are and the benefits our corporate and individual members receive.